This 9th Royal Marsden Lung Cancer Symposium will tackle burning issues and key challenges facing clinicians treating patients with lung cancer. We have assembled a combination of highly knowledgeable faculty members who will be talking on topics including, lung cancer screening, biomarker testing, systemic and local therapies in both NSCLC and SCLC. It will also involve discussions and debate on the pros and cons of treating oligometastatic NSCLC and put data in context with panel-based case-discussions.
This conference runs every 2 years with a multi-disciplinary audience composed of all healthcare professionals including medical, nursing and other allied healthcare professionals involved in the treatment and management of patients with lung cancer.